Food And Drug Administration-Coronary Artery Disease-Cushing's Syndrome-Drug-Eluting Stent

Korlym Approved for Cushing's Syndrome

MONDAY, Feb. 20 (Healthday News) -- Korlym (mifepristone) has been approved by the U.S. Food And Drug Administration to treat endogenous Cushing's syndrome, a disabling disorder caused by overproduction of the so-called "stress hormone," cortisol. read more..

source:http://yhoo.it/zOS3sN

Medtronic Stent Approved to Treat Coronary Artery Disease

TUESDAY, Feb. 21 (Healthday News) -- Medtronic's Resolute Integrity Drug-Eluting Stent has been approved by the U.S. Food And Drug Administration for people with coronary artery disease (CAD), the Minneapolis-based company said in a news release. read more..

source:http://yhoo.it/xIdotA